| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_916075766043ce900399a4c2eee9f054 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 |
| filingDate |
1993-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1996-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f43cdcf90d568600680a5ceeb2c787ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4b96307c75fc00ea31aef1f8ee8a575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27a4432647f8c102c2a5a73f1e0733ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f78c98ac79e3b7676f71966b21b42924 |
| publicationDate |
1996-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0558468-B1 |
| titleOfInvention |
Medicament for inhibiting nitric oxide formation |
| abstract |
The use is disclosed of methylguanidine or dimethylguanidine for the manufacture of a medicament particularly suitable for inhibiting nitric oxide formation in a warm blooded mammal. A pharmaceutical composition is disclosed containing methylguanidine or dimethylguanidine or a pharmaceutically acceptable salt thereof which is suitable in the treatment and/or prevention of diabetes-induced vascular dysfunction and complications in humans. <IMAGE> <IMAGE> |
| priorityDate |
1992-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |